Efficacy Comparison Between Primary Care Physicians' Independent Auscultation and AI-assisted Auscultation for Congenital Heart Disease Screening in Patient-enriched Populations: a Randomized Controlled Trial
- Conditions
- Congenital Heart Disease (CHD)Screening ToolArtifical IntelligenceRandomised Controlled TrialAuscultation for Clinical Evaluation
- Registration Number
- NCT06791096
- Lead Sponsor
- Kun Sun
- Brief Summary
In recent years, the application of artificial intelligence (AI) in the healthcare domain has witnessed a significant surge, with deep learning emerging as a potent force in the medical field. Deep learning algorithms possess the remarkable ability to automatically extract intricate features and patterns, thereby facilitating highly accurate heart sound recognition. Drawing on this technological advancement, Professor Sun Kun and his research team from Xinhua Hospital, in collaboration with numerous centers spanning across China, have been diligently investigating the development and application of AI-assisted heart sound recognition for congenital heart disease (CHD) screening.
Utilizing electronic stethoscopes to meticulously collect heart sounds, and harnessing AI algorithms to analyze extensive datasets comprising heart sounds from both children diagnosed with CHD and those who are healthy, the system has been trained to adeptly differentiate between normal and pathological murmurs. The current iteration of the system boasts an impressive accuracy and sensitivity rate of 90%.
This study is designed as a randomized controlled trial (RCT) to be conducted at Shanghai Xinhua Hospital and Qinghai Provincial Women and Children's Hospital. The primary objective is to demonstrate the superiority of AI-assisted primary care physicians in identifying CHD over primary care physicians working independently. This will be achieved by conducting a comparative analysis of the performance of AI-assisted physicians versus their unassisted counterparts, thereby substantiating the model's practical applicability. Through an ongoing process of refinement and widespread application, this pioneering research endeavors to empower a diverse range of medical professionals, including general practitioners, child health physicians, and non-cardiovascular specialists, with the transformative capabilities of AI-assisted electronic auscultation. The ultimate goal is to elevate the standard of pediatric care across the nation.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 420
- Age between 0 to 18 years, with no gender restrictions.
- Children who consent to undergo echocardiography to determine the presence or absence of congenital heart disease.
- Voluntary participation in this study and signing of an informed consent form.
- Age greater than 18 years.
- Children who are unable to undergo echocardiography or who do not cooperate with auscultation.
- Participants who cannot provide informed consent or are unwilling to comply with study requirements to provide medical data for further analysis and research.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Sensitivity of auscultation in CHD detection: Primary Care Physicians' Independent Auscultation & AI-Assisted Auscultation From enrollment to the end of treatment at 3 months
- Secondary Outcome Measures
Name Time Method Specificity, accuracy, and false negatives of auscultation in CHD detection: Primary Care Physicians' Independent Auscultation & AI-Assisted Auscultation From enrollment to the end of treatment at 3 months Specificity, accuracy, and false negatives of auscultation in CHD detection: Specialist Physicians' Independent Auscultation & AI-Assisted Auscultation By Primary Care Physician From enrollment to the end of treatment at 3 months Sensitivity, specificity, accuracy, and false negatives of auscultation in CHD detection: Primary Care Physicians' Independent Auscultation & AI Model From enrollment to the end of treatment at 3 months Specificity, accuracy, and false negatives of auscultation in CHD detection: Specialist Physicians' Independent Auscultation & Primary Care Physicians' Independent Auscultation From enrollment to the end of treatment at 3 months Sensitivity, specificity, accuracy, and false negatives of auscultation in CHD detection: Specialist Physicians' Independent Auscultation & AI Model From enrollment to the end of treatment at 3 months The rate of diagnostic revisions by physicians, the proportions of correct and incorrect changes From enrollment to the end of treatment at 3 months
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (2)
Qinghai Provincial Women and Children's Hospital
🇨🇳Qinghai, China
Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
🇨🇳Shanghai, China